144 related articles for article (PubMed ID: 3844972)
21. Potentiation of rat colon intraepithelial lymphocyte (IEL) natural killer (NK) activity with indomethacin.
Ross DS; Roy TR
Adv Exp Med Biol; 1987; 216A():527-31. PubMed ID: 3687538
[No Abstract] [Full Text] [Related]
22. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
[TBL] [Abstract][Full Text] [Related]
23. Natural killer, lymphokine-activated killer and interferon-gamma producing activities of peripheral blood- and regional lymph node-mononuclear cells in 23 cases of colorectal cancer.
Matsunaga H; Kuwahara Y; Kusugami K; Morise K; Shimokata K
Gastroenterol Jpn; 1988 Oct; 23(5):527-33. PubMed ID: 3145895
[TBL] [Abstract][Full Text] [Related]
24. Effects of levamisole on human natural killer and killer cell activity and production of interferons.
Liberati M; Borden EC; McBain JA; Raubertas R
Immunopharmacology; 1982 Oct; 5(1):11-8. PubMed ID: 6182126
[TBL] [Abstract][Full Text] [Related]
25. Impaired local natural killer cell activity in human colorectal carcinomas.
Aparicio-Pagés NM; Verspaget HW; Peña SA; Lamers CB
Cancer Immunol Immunother; 1989; 28(4):301-4. PubMed ID: 2495180
[TBL] [Abstract][Full Text] [Related]
26. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
Platsoucas CD
Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
[TBL] [Abstract][Full Text] [Related]
27. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
Platsoucas CD; Oleszak EL; Good RA
Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
[TBL] [Abstract][Full Text] [Related]
28. Modulation of human natural killer cell activity by recombinant human interleukin 2.
Shaw AR; Bleackley RC; Merryweather JP; Barr PJ
Cell Immunol; 1985 Mar; 91(1):193-200. PubMed ID: 3871664
[TBL] [Abstract][Full Text] [Related]
29. Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patients.
Itoh K; Pellis NR; Balch CM
Cancer Immunol Immunother; 1989; 29(1):57-62. PubMed ID: 2785000
[TBL] [Abstract][Full Text] [Related]
30. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
[TBL] [Abstract][Full Text] [Related]
31. Decreased natural killer cell activity after prolonged administration of interferon in cancer patients.
Bravo Cuellar A; Martin Ruiz JL; Orbach-Arbouys S
Immunol Lett; 1985; 10(3-4):137-9. PubMed ID: 4044011
[TBL] [Abstract][Full Text] [Related]
32. The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma.
Kikuchi Y; Oomori K; Kizawa I; Kato K
Jpn J Clin Oncol; 1985 Jun; 15(2):377-83. PubMed ID: 3839542
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.
Herlyn D; Herlyn M; Steplewski Z; Koprowski H
Eur J Immunol; 1979 Aug; 9(8):657-9. PubMed ID: 499332
[TBL] [Abstract][Full Text] [Related]
34. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
35. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD
Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of histamine receptor antagonists on human natural killer cell activity.
Hellstrand K; Hermodsson S
Int Arch Allergy Appl Immunol; 1987; 84(3):247-55. PubMed ID: 2443458
[TBL] [Abstract][Full Text] [Related]
37. PHA-ICC, ADCC and NK in patients with ANLL in CR: human fibroblastic interferon fails to increase NK-active cell frequency.
Fontana L; De Rossi G; De Sanctis G; Bottari V; Avvisati G; Perricone R; Mandelli F
Leuk Res; 1984; 8(5):885-91. PubMed ID: 6492856
[TBL] [Abstract][Full Text] [Related]
38. Effect of recombinant human interferons on NK and K cell activities of gnotobiotic miniature swine.
Kim YB; Chung TJ
Prog Clin Biol Res; 1985; 181():329-32. PubMed ID: 3927308
[No Abstract] [Full Text] [Related]
39. Enhancement of cytotoxic activity of natural killer cells by interleukin 2, and antagonism between interleukin 2 and adenosine cyclic monophosphate.
Chun M; Krim M; Granelli-Piperno A; Hirst JA; Hoffmann MK
Scand J Immunol; 1985 Oct; 22(4):375-81. PubMed ID: 2416040
[TBL] [Abstract][Full Text] [Related]
40. Natural killer and antibody-dependent cellular cytotoxicity in cervical carcinoma patients.
Satam MN; Suraiya JN; Nadkarni JJ
Cancer Immunol Immunother; 1986; 23(1):56-9. PubMed ID: 3094944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
